Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Action Needed On Competition And Shortages

JAMA Study Of FDA Data Calls For More ANDA Approvals

Executive Summary

A study published by the Journal of the American Medical Association found that, despite a recent stream of FDA activity, the proportion of approvals for drugs that faced limited competition or had previously been in shortage remained steady.

You may also be interested in...



AAM Commits To Work With FDA On Shortages

The AAM has commended the FDA’s efforts on identifying the root causes of drug shortages in 2019 and has committed to work with the agency in pursuit of a “healthy, sustainable market for safe, effective and affordable medicines for patients.”

FDA Breaks Record On Approvals

As the FDA breaks its record for generic drug approvals in fiscal year 2019, it emphasizes the importance of consumer confidence in the safety and quality of approved generics. 

US FDA Generic Approvals Break 900 Barrier In FY 2019

The record number of full ANDA approvals also exceeded submissions for the first time since GDUFA was enacted.

Topics

Latest News
See All
UsernamePublicRestriction

Register

GB149269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel